⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 9, 2024Neurology

Matching-adjusted Indirect Comparison of Current Treatments for NMOSD and Evaluation of Long-term Effectiveness (P10-14.006)

Friedemann Paul Orhan Aktaş Mikkel Melters Pedersen Francesc Sorio-Vilela Kristina Patterson Nishi Rampal Daniel Cimbora Bruce Cree

View at Publisher

Ask AI

Bookmark

Share

Abstract

To perform a matching adjusted indirect comparison (MAIC) utilizing investigator adjudicated attacks (IAA) as a sensitivity analysis to further support the relative effectiveness of inebilizumab relative to other current Neuromyelitis Optica Spectrum Disorder (NMOSD) therapies.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Paul et al. (2024) studied this question.

synapsesocial.com/papers/68e6fdb8b6db643587678137 https://doi.org/10.1212/wnl.0000000000204722

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A Critical Appraisal of Matching-Adjusted Indirect Comparisons in Spinal Muscular AtrophyMeta-Analysis · 2023 · 11 citations
2Optimizing covariate selection and results inference in anchored matched adjusted indirect comparison method2024
3Long-term Comparative Efficacy of Inebilizumab in the AQP4+ Subpopulation from N-MOmentum Open-label Period Versus Azathioprine and Immunosuppressants and Versus Placebo in Patients with NMOSD (S32.001)2024
4Matching-adjusted indirect treatment comparisons in chronic inflammatory demyelinating polyneuropathy: interpreting current evidence and enhancing future studiesMeta-Analysis · 2026
5The Importance of Clinical Context and Consistency in Methodology When Using Matching-Adjusted Indirect Comparisons (MAICs) to Compare Outcomes2024 · 2 citations